4Mizoguehi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models [J]. J Gastroentero1,2008,43 ( 1 ) : 1-17.
5Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history [J]. Expert Rev Gastroenterol Hepatol,2009,3 (5) :513-534.
6Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County,2003-2005: a population-based study from the Danish Crohn colitis database [J]. Am J Gastroenterol, 2006,101 ( 6 ) : 1274-1282.
7Lichtenstein GR, Diamond RH, Wagner CL, et al. Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials [J]. Aliment Pharmacol Ther,2009,30( 3 ) :210-226.
8Wang P, Hou SX. Regulation of intestinal stem cells in mammals and Drosophila [J]. J Cell Physiol,2010,222( 1 ) :33-37.
9Clavin NW, Fernandez J, Schonmeyr BH, et al. Fractionated doses of ionizing radiation confer protection to mesenchymal stem cell pluripotency [J]. Plast Reconstr Surg,2008,122 ( 3 ) :739-748.
10Drakos PE,Nagler A, Or R. Case of Crohn' s disease in bone marrow transplantation [J]. Am J Hematol, 1993,43 (2) : 157- 158.
